CSIMarket Company Name, Ticker, Suppliers, else..
 
Neximmune Inc   (NEXI)
 
Price: $0.0001 $0.00 0.000%
Day's High: $0.00009999999747378752 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: 0.00
Volume (M): 0 52 Wk High: $ 0.01
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 1
 Employees 40
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -21
 Cash Flow (TTM) (Millions $) -14
 Capital Exp. (TTM) (Millions $) 0

Business Description


Neximmune Inc is a biotechnology company that specializes in developing novel immunotherapies for the treatment of various diseases. The company focuses on next-generation T-cell therapies to harness the power of the immune system to target and eliminate cancer cells. Neximmune's platform technology utilizes the body's natural defense mechanisms to create personalized therapies that are specifically tailored to each patient. By leveraging their expertise in molecular immunology, the company aims to revolutionize the field of immunotherapy and provide innovative treatment options for patients.


   Company Address: 9119 Gaither Road Gaithersburg, 20877 MD
   Company Phone Number: 825-9810   Stock Exchange / Ticker: NEXI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ADCT   -6.76%    
NRIX   -0.93%    
NVS        2.3% 
RYTM   -3.17%    
SUPN        2.95% 
YMAB        0.35% 
• View Complete Report
   



Stocks on the Move

Navigating a Divergent Path Nvidias Rise and NexImmunes Struggles in the Stock Market

Published Wed, Aug 7 2024 7:22 PM UTC

The financial markets are often a stage where contrasting fortunes play out in real time, painting a picture of industry trends and investor sentiment. This past month has been particularly telling, exemplified by the stark contrast between two companies: Nvidia and NexImmune. Nvidia: The AI Titan On July 29, 2024, Nvidia (NASDAQ: NVDA), the frontline warrior in the artifici...
Financing Agreement

NexImmune's Financial Dilemma: High Leverage Ratio Despite Successful Offerings

Published Tue, Feb 6 2024 9:43 PM UTC


NexImmune s Tangible Leverage Ratio Reaches New All-Time High Despite Borrowings
NexImmune recently announced the closing of a $3.67 million registered direct offering priced at-the-market under Nasdaq rules. This comes at a time when the company s Tangible Leverage Ratio has deteriorated to 0.76 in the third quarter of 2023, reaching a new all-time high.
In com...
Shares

NexImmune's Registered Direct Offering Positions Company for Further Growth and Development

Published Fri, Feb 2 2024 7:00 PM UTC


In an exciting move that reflects the ongoing progress and potential of NexImmune Inc, the company has recently announced a registered direct offering priced at-the-market under Nasdaq rules. The offering, totaling $3.67 million, signifies a significant step forward for NexImmune as it seeks to leverage its innovative immunotherapy platform to address unmet medical need...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 0
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.51
Working Capital Ratio 0.66
Leverage Ratio (MRQ) 7.42
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -18.66 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 1.76 $
Book Value 0.5 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -515,421
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.